HSS: strength training prevents GLP‑1 muscle loss

- Hospital for Special Surgery advised targeted strength exercises to help prevent sarcopenia in patients losing weight on GLP‑1 drugs like Ozempic and Wegovy. (news.hss.edu) - HSS outlined three specific strength moves aimed at preserving lean mass during GLP‑1 induced weight loss. (news.hss.edu) - The recommendation sits alongside studies showing higher psychiatric disorder risk in some GLP‑1 cohorts, underlining the need for medical supervision. (theglobeandmail.com) (washingtontimes.com)

GLP-1 drugs are very good at helping people lose weight. But your body does not automatically choose to lose only fat. Some of that weight can come from lean mass — muscle, water, and other fat-free tissue — especially when weight comes off fast. That is the problem Hospital for Special Surgery was trying to address this week when it highlighted a simple idea: if you want to keep muscle while taking drugs like Ozempic or Wegovy, you need to give your body a reason to keep it. (news.hss.edu) ### Why is muscle loss part of the conversation? Because it is not a weird GLP-1-only side effect. Rapid weight loss of almost any kind tends to pull some lean mass down with it. The difference with GLP-1s is scale — these drugs can drive big appetite reductions and meaningful weight loss, so the muscle-preservation question shows up fast in real clinical practice. A recent JAMA Internal Medicine review put lean body mass loss during GLP-1 treatment in roughly the 25% to 40% range of total weight lost, while also stressing that exercise and nutrition can blunt that loss. (jamanetwork.com) ### What did HSS actually say? HSS amplified guidance from its exercise physiologists through media coverage published April 30. The message was practical, not exotic: strength training helps tell the body to keep muscle during weight loss. In the HSS material, Jamie Pasquin walked through three basic resistance moves meant to hit the big lower-body muscle groups that matter for strength and function. A related HSS piece made the same point even more plainly — strength work signals that muscle is still needed. (news.hss.edu) ### Which exercises are they pushing? The emphasis was on foundational moves, not biohacking. HSS highlighted three strength exercises — the kind of compound lower-body work that trains glutes, quads, and hamstrings together and scales well for beginners. That matters because preserving muscle is less about finding a magical movement and more about creating regular mechanical tension the body interprets as “do not throw this tissue away.” (news.hss.edu) ### Why lower-body strength in particular? Because those are your biggest muscle groups, and they are the ones that carry the most day-to-day function. If weight loss strips too much muscle from the legs and hips, the cost is not just aesthetic. It can show up in balance, mobility, power getting out of a chair, and long-term frailty risk. That is why muscle preservation on GLP-1s is really a health-span issue, not a gym vanity issue. (news.hss.edu) ### Is lifting enough by itself? Not really. The catch is that resistance training works best as part of a bundle — enough protein, enough calories to avoid extreme underfueling, and a pace of weight loss that is not too aggressive. Harvard’s guidance on weight loss and muscle says the same thing in broader terms: resistance training, adequate protein, and avoiding crash-style loss all help protect lean mass. Basically, the drug lowers intake; the rest of the plan has to protect the parts of you that intake used to support. (jamanetwork.com) ### What about the psychiatric-risk angle? This part is messier than some headlines make it sound. One recent Lancet Psychiatry study did report an association between GLP-1 use and worsening mental-health outcomes in a specific Swedish cohort with depression or anxiety disorders. But other newer evidence cuts the other way — including a Nature Molecular Psychiatry paper that did not find increased suicide or suicide-attempt risk, plus a JAMA Psychiatry meta-analysis that also did not show elevated suicidality in randomized trials. So the real takeaway is supervision, not panic. (thelancet.com) ### Who should care most? People already at higher risk of muscle loss — older adults, people with low baseline strength, people eating very little on these drugs, and anyone treating obesity while also managing other chronic illness. For them, “weight loss” is too blunt a goal. Body composition and function matter more. (pmc.ncbi.nlm.nih.gov) ### Bottom line The useful shift here is simple. GLP-1 treatment is no longer just about how much weight comes off. It is about what stays. HSS’s advice lands because it turns that abstract concern into something concrete — pick up resistance, train consistently, and make the weight you lose more likely to be fat instead of muscle. (news.hss.edu)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.